The global burden of inflammatory bowel disease (IBD) is currently significant and continues to grow due to the increasing prevalence of ulcerative colitis (UC) and Crohn's disease (CD), the increasing costs of diagnosis and treatment, and the high level of disability in patients with this disease. Categories, which leads to the search for risk factors and predictors of aggressive course and extraintestinal manifestations. According to the latest data, the prevalence of UC in Russia is 16.
View Article and Find Full Text PDFUnited European Gastroenterol J
February 2024
Unlabelled: It is a matter of current interest which rifaximin-α regimens in patients with liver cirrhosis and minimal hepatic encephalopathy are the most efficient.
Study Objective: to evaluate the effect of various rifaximin-α regimens for 12 months on clinical and laboratory parameters and quality of life in patients with liver cirrhosis and minimal hepatic encephalopathy.
Methods: It was a multicenter, prospective, open-label, observational study that included 288 patients with liver cirrhosis and minimal hepatic encephalopathy of both sexes over the age of 18 years, who were prescribed a 12-month course of treatment with rifaximin-α in accordance with the product label.
Phys Chem Chem Phys
August 2023
Local processes inside the ion solvation shell are believed to be the main factor affecting ion reduction in battery electrolytes. Much less attention is devoted to the interaction between the ion and molecules outside the shell. We demonstrate that in recently developed divalent batteries, long range ion/solvent and ion/electrode interactions significantly affect the reduction of ions.
View Article and Find Full Text PDF